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Uropathogenic Escherichia coli (UPEC) is responsible for the majority of urinary tract infections (UTI). To cause a UTI, UPEC
must adhere to the epithelial cells of the urinary tract and overcome the shear flow forces of urine. This function is mediated
primarily by fimbrial adhesins, which mediate specific attachment to host cell receptors. Another group of adhesins that contrib-
utes to UPEC-mediated UTI is autotransporter (AT) proteins. AT proteins possess a range of virulence properties, such as adher-
ence, aggregation, invasion, and biofilm formation. One recently characterized AT protein of UPEC is UpaH, a large adhesin-
involved-in-diffuse-adherence (AIDA-I)-type AT protein that contributes to biofilm formation and bladder colonization. In this
study we characterized a series of naturally occurring variants of UpaH.We demonstrate that extensive sequence variation exists
within the passenger-encoding domain of UpaH variants from different UPEC strains. This sequence variation is associated with
functional heterogeneity with respect to the ability of UpaH to mediate biofilm formation. In contrast, all of the UpaH
variants examined retained a conserved ability to mediate binding to extracellular matrix (ECM) proteins. Bioinformatic
analysis of the UpaH passenger domain identified a conserved region (UpaHCR) and a hydrophobic region (UpaHHR). Dele-
tion of these domains reduced biofilm formation but not the binding to ECM proteins. Despite variation in the upaH se-
quence, the transcription of upaH was repressed by a conserved mechanism involving the global regulator H-NS, and mu-
tation of the hns gene relieved this repression. Overall, our findings shed new light on the regulation and functions of the
UpaH AT protein.
Uropathogenic Escherichia coli (UPEC) is the major cause ofurinary tract infections (UTI) in humans. Infection of the
urinary tract by UPEC involves initial adherence to uroepithelial
cells to resist the hydrodynamic forces of urine flow and subse-
quent inflammation triggered by host and bacterial cell signaling
pathways. UPEC can also invade bladder epithelial cells, replicate,
and establish biofilm-like intracellular bacterial communities
(IBCs) that contain large numbers of bacteria (3, 20, 49, 55).
UPEC possesses a range of virulence factors, including ad-
hesins (e.g., type 1 and P fimbrial), toxins (e.g., hemolysin), and
siderophore-mediated systems for iron acquisition (e.g., entero-
bactin, salmochelin, aerobactin), that enable them to colonize the
urinary tract and cause disease (37, 62, 80). Adhesion represents a
critical initial step for UPEC colonization of the urinary tract and
is mediated primarily by fimbriae. However, UPEC also produces
a number of autotransporter (AT) proteins that contribute with
varying degrees to adherence, aggregation, and biofilm formation
(1, 2, 72, 74). Several AT proteins have been characterized from
UPEC, and these include the secreted toxin Sat (19, 23, 41), the
phase-variable outer membrane protein antigen 43 (Ag43) (35,
72), the trimeric AT protein UpaG (74), and the surface-located
UpaB, UpaC, and UpaH proteins (1, 2).
AT proteins represent a major group of Gram-negative bacte-
rial secreted proteins and share several common features: an N-
terminal signal sequence, a passenger () domain that is either
anchored to the cell surface or released into the external milieu,
and a translocation () domain that resides in the outer mem-
brane (28, 33). AT proteins were originally thought to possess
structural properties that facilitate their independent transport
across the bacterial membrane system and final routing to the cell
surface (29). However, it has been shown that accessory factors,
such as the -barrel assembly machinery (Bam) complex (also
known as the YaeT or Omp85 complex), as well as periplasmic
chaperones, such as SurA, Skp, and DegP, are required for the
secretion of some AT proteins (32, 52, 56–58, 60, 76). Most re-
cently, a new translocation and assemblymodule (TAM) that pro-
motes the efficient secretion of AT proteins in proteobacteria has
been described (63). The passenger domain of AT proteins is the
most divergent in sequence and confers the functional character-
istics of the protein. It is frequently associated with virulence (29).
The most diverse subgroup of AT proteins is the adhesin-in-
volved-in-diffuse-adherence (AIDA-I) type (29, 78). Of the 11
putative AT-encoding genes that have been identified in the se-
quenced genome of the prototype UPEC strain CFT073, 7 belong
to this subgroup. Ag43 represents the best-characterized UPEC
AIDA-I-type AT protein. Ag43 (encoded by the flu gene) is a self-
recognizing AT protein that contributes to E. coli biofilm forma-
tion (13, 35, 61, 79). Ag43 expression by UPEC is associated with
IBC formation (3) and long-term colonization of the mouse uri-
nary tract (72).
Recently we identified and characterized the UpaHAT protein
from the UPEC strain CFT073 (2). UpaH is the largest AIDA-I-
type AT protein characterized from E. coli and contributes to bio-
film formation and bladder colonization in a mouse UTI model.
In this study, we investigated upaH gene expression in different
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UPEC isolates and identified the global regulator H-NS as a tran-
scriptional repressor. Using hns gene deletion mutants, we dem-
onstrated that upaH transcription is derepressed in multiple
UPEC backgrounds.While we found the transcription of upaH to
be regulated similarly in different UPEC strains, we showed that
the coding sequence contains significant variation, particularly in
the passenger-encoding domain. This sequence variation results
inUpaHprotein variantswith distinct biofilm-forming properties
but a conserved ability to bind extracellular matrix proteins.
Bioinformatic analysis of the UpaH passenger domain also iden-
tified conserved and hydrophobic regions, and we have shown
that these regions contribute to biofilm formation.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains and plasmids used
in this study are listed in Table 1. Cells were routinely grown at 28°C or
37°C on solid or in liquid lysogeny broth (LB) medium (8) supplemented
with the appropriate antibiotics: kanamycin (Kan, 50 g/ml), chloram-
phenicol (Cam, 30 g/ml), or ampicillin (Amp, 100 g/ml). For growth
under defined conditions,M9minimalmedium supplementedwith 0.2%
glucose was used (59).
DNA manipulations and genetic techniques. DNA techniques were
performed as described by Sambrook and Russell (59). The isolation of
plasmid DNA was carried out using the QIAprep spin miniprep kit
(Qiagen). Restriction endonucleases were used according to themanufac-
turer specifications (New England BioLabs). Chromosomal DNA purifi-
TABLE 1 Bacterial strains and plasmids used in this study
Strain or plasmid Relevant characteristics Reference
E. coli K-12 strains
OS56 MG1655flu attB::bla-gfp Gfp Ampr 65
OS56(pBAD) OS56 pBAD/myc-HisA 77
OS56(pUpaHCFT073) pUpaHCFT073 in OS56, Ampr Kanr 2
OS56(pUpaHM161) pUpaHM161 in OS56, Ampr Kanr This study
OS56(pUpaHM357) pUpaHM357 in OS56, Ampr Kanr This study
OS56(pUpaHM369) pUpaHM369 in OS56, Ampr Kanr This study
OS56(pUpaHIA2) pUpaHIA2 in OS56, Ampr Kanr This study
OS56(pUpaHHR) pUpaHCFT073 with no hydrophobic region in OS56, Ampr Kanr This study
OS56(pUpaHCR) pUpaHCFT073 with no conserved region in OS56, Ampr Kanr This study
E. coli UPEC strains
CFT073 Wild-type UPEC isolate 47
CFT073upaH CFT073upaH::kan Kanr 2
CFT073hns CFT073c1701::kan Kanr 1
CFT073lacIZ CFT073lacIZ::cam Camr 1
CFT073lacIZ upaH::lacZ-zeo CFT073lacIZ::cam upaH::lacZ-zeo Camr Zeor This study
CFT073lacIZ upaH::lacZ-zeo hns::kan CFT073lacIZ::cam upaH::lacZ-zeo c1701::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo hns::kan pBR322 CFT073lacIZ::cam upaH::lacZ-zeo c1701::kan pBR322 Camr Zeor Kanr Ampr This study
CFT073lacIZ upaH::lacZ-zeo hns::kan pH-NS CFT073lacIZ::cam upaH::lacZ-zeo c1701::kan pH-NS, Camr Zeor Kanr Ampr This study
CFT073lacIZ upaH::lacZ-zeo c0421::kan CFT073lacIZ::cam upaH::lacZ-zeo c0421::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c1699::kan CFT073lacIZ::cam upaH::lacZ-zeo c1699::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c2091::kan CFT073lacIZ::cam upaH::lacZ-zeo c2091::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c2411::kan CFT073lacIZ::cam upaH::lacZ-zeo c2411::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c3218::kan CFT073lacIZ::cam upaH::lacZ-zeo c3218::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c3244::kan CFT073lacIZ::cam upaH::lacZ-zeo c3244::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c3744::kan CFT073lacIZ::cam upaH::lacZ-zeo c3744::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c4864::kan CFT073lacIZ::cam upaH::lacZ-zeo c4864::kan Camr Zeor Kanr This study
CFT073lacIZ upaH::lacZ-zeo c5054::kan CFT073lacIZ::cam upaH::lacZ-zeo c5054::kan Camr Zeor Kanr This study
M161 Wild-type UPEC isolate 2
M161upaH M161upaH::kan Kanr 2
M161hns M161hns::kan Kanr This study
M357 Wild-type UPEC isolate 2
M357upaH M357upaH::kan Kanr 2
M357hns M357hns::kan Kanr This study
M369 Wild-type UPEC isolate This study
M369upaH M369upaH::kan Kanr This study
M369hns M369hns::kan Kanr This study
IA2 Wild-type UPEC isolate 11
IA2upaH IA2upaH::kan Kanr This study
IA2hns IA2hns::kan Kanr This study
Plasmids
pBR322 Ampr Tetr 9
pH-NS pBR322 c1701 (H-NS) from CFT073, Ampr 1
pKOBEG pSC101 ts (replicates at 30°C), araC, arabinose-inducible -red operon, Camr 10
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cation was performed using the DNeasy blood and tissue kit (Qiagen).
Oligonucleotides were purchased from Sigma (Australia or France). All
PCRs were performed with the Expand high-fidelity polymerase sys-
tem (Roche) or Phusion (Finnzymes) as described by the manufactur-
ers. The in vitro transposon mutagenesis employed was performed as
previously described using the primers Kan-2 FP-1 (5=-ACCTACAAC
AAAGCTCTCATCAACC) and Kan-2 RP-1 (5=-GCAATGTAACATCAG
AGATTTTGAG) (2). DNA sequencing was performed using the ABI Big-
Dye v3.1 kit (ABI) by the Australian Equine Genetics Research Centre
(University of Queensland, Brisbane, Australia).
Construction of plasmids. The plasmids pUpaHM161, pUpaHM357,
pUpaHM369, and pUpaHIA2 contain the upaH gene from strains M161,
M357, M369, and IA2, respectively, and were created by PCR amplifica-
tion using the primers 520 (5=-CGCGCTCGAGATAATAAGGAATTATT
ATGCAAAGGAAAACTCTATTGTCG) and 521 (5=-CGCGCAAGCTTT
TAGAATGTTTTCTTGAAGT), digestion with XhoI-HindIII, and
insertion into the XhoI-HindIII-digested vector pBAD/myc-HisA. A final
modification of the plasmid was made by inserting a kanamycin resis-
tance-encoding gene into the HindIII site. Resistance to kanamycin was
required to facilitate the transformation of these plasmids into the flu-
negative gfp-positive K-12 strain OS56. In the pUpaH vectors, the expres-
sion of upaH is under the control of the arabinose-inducible araBAD
promoter (24).
Construction of deletions and mutants. Mutants containing dele-
tions in the upaH gene were constructed by -red-mediated homologous
recombination as previously described (2, 14). We created lacZ reporter
transcriptional fusions or interrupted the regulator genes in strain
CFT073 using homologous recombination mediated by -red recom-
binase expressed from the pKOBEG plasmid (15) and either a one-step
PCR procedure with 40-bp homology arms for recombination or a
three-step PCR procedure with 500-bp homology arms for recombination
(15) (http://www.pasteur.fr/recherche/unites/Ggb/matmet.html). lacZ re-
porter transcriptional fusions were constructed using the primers upaH-lac-
Zzeo-Long-5 (5=-GGGTATCCGACCTTCTTTATATTCGCCAGAAGGA
TTTATTATGACCATGATTACGGATTCACTG-3=) and upaH-lacZeo-
Long-3 (5=-CCTGTATCAGCGTTGCGGTTTATGTATTACATGCTAA
AAATCAGTCCTGCTCCTCGGCCACGAA-3=). lacZ mutants were
confirmed via PCR using the primers upstream region (upaH.ext-5
5=-CAGGGGCGGGTAGGGGAAACAT-3= and lacZATG 100-3 5=-GG
GGGATGTGCTGCAAGGCGATTAAG-3=) and downstream region
(zeo.verif-5 5=-ACGAACTTCCGGGACGCCTCCG-3= and upaH.ext-3
5=-CCATGACCATCCCCCATCAT-3=). The primers were designed and
used as described previously to mutate the upaH gene (2) and the set of
regulatory genes examined (1). All mutants were confirmed via PCR and
sequencing using the primers Gene.ext 5= and Gene.ext 3=, either as a
primer set or individually in combination with internal primers designed
to bind within the inserted DNA fragments.
Immunoblotting andglycoprotein staining.Apolyclonal anti-UpaH
serum raised against a portion of the passenger domain of UpaH from
strain CFT073 was used for UpaH detection (2). For immunoblotting,
whole-cell lysates were subjected to SDS-PAGE using NuPAGE Novex 3
to 8% Tris-acetate precast gels with NuPAGE Tris-acetate running buffer
and subsequently transferred to polyvinylidene difluoride (PVDF)micro-
porous membrane filters using the iBlot dry-blotting system as described
by the manufacturer (Invitrogen). Serum raised against the passenger
subunit of UpaH was used as the primary serum, and the secondary anti-
body was alkaline phosphatase-conjugated anti-rabbit IgG. Sigma fast
5-bromo-4-chloro-3-indolylphosphate (BCIP)/nitroblue tetrazolium(NBT)
was used as the substrate in the detection process. Glycoprotein staining
was performed using the Pierce glycoprotein staining kit per the manu-
facturer’s instructions.
Biofilm assays. Flow cells were inoculated with optical density at 600
nm (OD600)-standardized cultures pregrown overnight in glucose M9
minimal medium. For E. coli OS56 biofilms, kanamycin was added as
required for themaintenance of plasmids. Biofilmdevelopmentwasmon-
itored by confocal scanning laser microscopy 16 h or 24 h after inocula-
tion. For analysis of the flow cell biofilms, we collected 6 z-stacks for each
strain and analyzed them by using the COMSTAT software program (31).
All experiments were performed in duplicate. COMSTAT data were ana-
lyzed using the nonparametric Kruskal-Wallis test within the Minitab
(v14) software package. P values of0.05 were considered significant.
Extracellular matrix protein binding assays. Bacterial binding to ex-
tracellular matrix (ECM) proteins was performed in a microtiter plate
enzyme-linked immunosorbent assay (ELISA) essentially as described
previously (74). Microtiter plates (MaxiSorp; Nunc) were coated over-
night at 4°C with MaxGel human extracellular matrix (10 g/ml) or with
2 g of the following ECM proteins: collagen IV, collagen V, fibronectin,
fibrinogen, laminin, and bovine serum albumin (BSA) (Sigma-Aldrich).
The wells were washed twice with Tris-buffered saline (TBS) (137 mM
NaCl, 10 mM Tris [pH 7.4]) and then blocked with TBS-2%milk for 1 h.
After being washed with TBS, 200 l of washed and standardized
(OD600 0.1) OS56 (containing pUpaH plasmids) or OS56(pBAD) was
added, and the plateswere incubated at 37°C for 2 h. After beingwashed to
remove nonadherent bacteria, adherent cells were fixed with 4% parafor-
maldehyde, washed, and incubated for 1 h with anti-E. coli serum (Me-
ridian Life Sciences Inc., catalog no. B65001R) diluted 1:500 in 0.05%
TBS-Tween and 0.2%milk, washed, and incubated for 1 h with a second-
ary anti-rabbit-conjugated horseradish peroxidase antibody (diluted
1:1,000) (Sigma-Aldrich, catalog no. A6154). After a final wash, the ad-
hered bacteria were detected by adding 150 l of 0.3 mg/ml ABTS [2,2=-
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)] (Sigma-Aldrich) in 0.1
M citric acid (pH 4.3) and activated with 1l/ml 30%hydrogen peroxide,
and the absorbance at 405 nm was read. The mean absorbance readings
were compared with negative control readings for OS56(pBAD) using
two-sample t tests within the Minitab v14 software package. P values of
0.05 were considered significant.
Investigation of hydrophobic and conserved regions of UpaH. The
hydrophobicity of the N-terminal 300 amino acids (aa) of UpaH was
analyzed using the Kyte-Doolittle scale in ProtScale (21, 38). To examine
the function of the hydrophobic and conserved regions in the -domain
of UpaH, the plasmids pUpaHHR (lacking nucleotides 193 to 267) and
pUpaHCR (lacking nucleotides 846 to 1416) were constructed. For the con-
structionof pUpaHHR, the primersUpaHHRF (5=-GCGCGCTCGAGATAA
TAAGGAATTCTTATGCAAAGGAAAACTCTA-3=) and UpaHHRR (5=-
GCGCGTGATCATCATCGTCGTTGACTACAGAGGAGCATTCAG-
3=) were used to PCR amplify the N-terminal region of the upaH gene
from pUpaHCFT073 without the predicted hydrophobic region. This PCR
product was then digested with XhoI/BclI and ligated with an XhoI/BclI-
digested pUpaHCFT073 plasmid. For the construction of pUpaHCR, the
overlapping oligonucleotides UpaHCRF (5=-TCGAGATAATAAGGAAT
TCTTATGCAAAGGAAAACTCTATTGTCGGCCTGTATTGCAT
TAGCTCTGAGTGGTCAGGGTTGGGCGGCAGATATTACAGAAC
ACAA-3=) and UpaHCRR (5=-TTGTGTTCTGTAATATCTGCCGCCCA
ACCCTGACCACTCAGAGCTAATGCAATACAGGCCGACAATAGAG
TTTTCCTTTGCATAAGAATTCCTTATTATC-3=) were resuspended in
100 mM potassium acetate and 30 mMHEPES to a concentration of 100
M, combined, heated to 99°C, and allowed to anneal by cooling at room
temperature. The overlapping oligonucleotides were designed to create
ends corresponding to digestion with XhoI/AleI upon annealing, and the
double-stranded product was ligated with the XhoI/AleI-digested
pUpaHCFT073 plasmid. The resultant pUpaHHR and pUpaHCR plasmids
were screened via EcoRI digestion, confirmed via sequencing, and trans-
formed into E. coli strain OS56 for phenotypic assays.
Microscopy and image analysis. An anti-UpaH-specific serum was
used for immunofluorescence microscopy essentially as described previ-
ously with the exception that an Alexa Fluor 350 goat anti-rabbit IgG
A11046 (Life Technologies) secondary antibody was used (2, 74). Immu-
nofluorescence microscopy and image acquisition were performed on a
scanning confocal laser microscope (Axioplan2; Zeiss) equipped with de-
tectors and filters for monitoring of the Alexa Fluor 350. Microscopic
Characterization of UpaH Homologues from UPEC Strains
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observations of biofilms and image acquisitionwere performed on a scan-
ning confocal laser microscope (LSM510 META; Zeiss) equipped with
detectors and filters for the monitoring of green fluorescent protein
(GFP). Vertical cross-sections through the biofilms were visualized using
the Zeiss LSM image examiner. The images were further processed for
display by using Photoshop software (Adobe, Mountain View, CA).
Cell surface hydrophobicity assay.Themicrobial adhesion to hydro-
carbons (MATH) assay was performed essentially as described previously
(44). Briefly, overnight cultures were washed twice, resuspended in saline,
and fixed to anOD600 of 0.3. In quadruplicate, 5-ml bacterial suspensions
were overlaidwith 0.4mln-hexadecane andmixed on a platform shaker at
37°C (400 rpm, 15 min). After 15 min of equilibration at room tempera-
ture, the lower aqueous phasewas removed, and theOD600 wasmeasured.
The hydrophobicity index (HPBI) was calculated as (ODinitial	ODfinal)/
ODinitial. The results were analyzed by the Kruskal-Wallis test.
-Galactosidase assays. -Galactosidase assays were performed es-
sentially as described previously (46). Briefly, the strains carrying lacZ
fusions were grown on LB plates for 16 h and then inoculated into LB
medium. After 16 to 18 h of growth, the culture was diluted in Z buffer (60
mM Na2HPO4, 40 mM NaH2PO4, 50 mM -mercaptoethanol, 10 mM
KCl, 1mMMgSO4 [pH 7]), 0.004%SDS and chloroformwere added, and
the samples were vortexed to permeabilize the cells. The samples were
incubated at 28°C, and the reaction was initiated by the addition of o-ni-
trophenyl--D-galactopyranoside (ONPG). The reactions were stopped
with the addition of sodium bicarbonate, and the enzymatic activity was
assayed in quadruplicate for each strain by measuring the absorbance at
420 nm.Where required,-galactosidase activity was also observed on LB
agar plates containing 5-bromo-4-chloro-3-indolyl -D-galactopyrano-
side (X-Gal).
Electrophoretic mobility shift assay.Gel shift assays were performed
essentially as described previously (5). A DNA mixture comprising the
PCR-amplified upaH promoter region and TaqI-SspI-digested pBR322 at
an equimolar ratio was incubated at room temperature for 15 min with
increasing amounts of native purified H-NS protein (a gift from S.
Rimsky) in 30l of a reactionmixture containing 40mMHEPES (pH 8),
60 mM potassium glutamate, 8 mMmagnesium aspartate, 5 mM dithio-
threitol, 10% glycerol, 0.1% octylphenoxypolyethoxyethanol, 0.1 mg/ml
BSA (H-NS-binding buffer). DNA fragments and DNA-protein com-
plexes were resolved by gel electrophoresis (0.5
 Tris-borate-EDTA
[TBE], 3% molecular screening [MS] agarose gel run at 50 V at 4°C) and
visualized after staining with ethidium bromide.
DNA curvature prediction andDNA PAGE analysis. The upaH pro-
moter region was analyzed in silico using BendIt, a program that enables
the prediction of a curvature-propensity plot calculated with DNase I-
based parameters (75). The curvature is calculated as a vector sum of
dinucleotide geometries (roll, tilt, and twist angles) and expressed as de-
grees per helical turn (10.5°/helical turn 1°/bp). Experimentally tested
curved motifs produce curvature values of 5 to 25°/helical turn, whereas
straight motifs give values below 5°/helical turn. The upaH 250-bp pro-
moter region was amplified using the primers upaH.pro.ext-5 250 (5=-
TTGATTTATACCGTTTTTTCATTA-3=), upaH.pro.ext-5 250B (5=-T
TGGTTTATACCGTTTTTTCATTA-3=), upaH.pro.ext-5 250C (5=-TG
GTTTATACCGTTTTTTTCATTA-3=), and upaH.pro.ext-3-1ATG (5=-A
ATAAATCCTTCTGGCGAATATAA-3=) and its intrinsic curvature was
assessed by comparing its electrophoretic mobility with that of a
100-bp DNA ladder (New England BioLabs) on a 0.5
 TBE, 7.5%
PAGE gel at 4°C.
Evolutionary and sequence analysis. The prevalence of the upaH
gene was analyzed in 61 complete and 247 draft E. coli genome sequences
available in theNCBI database. TheN-terminal 300-amino-acid sequence
was extracted from 139 strains and included 51 different sequences from
complete and intact genes. The sequences were compared and aligned
using Muscle, and their phylogenetic relationship was inferred using the
neighbor-joining method in MEGA5 (71). The genome context was ana-
lyzed and drawn using Easyfig (67).
Nucleotide sequence accession numbers. The complete nucleotide
sequences of the upaH gene from strains M161, M357, M369, and IA2
have been deposited in the NCBI database (BankIt submission ID
1482470, accession no. JN709850 through JN709854).
RESULTS
UpaH is expressed in multiple UPEC strains. We previously
demonstrated the expression of UpaH in three UPEC strains
(CFT073, M161, and M357) via Western blot analysis employing
UpaH-specific antibodies. In all three strains, the sizes of the
UpaH protein as assessed by SDS-PAGE analysis were similar (2).
Moreover, we showed that the upaH gene cloned and sequenced
from strain CFT073 encodes a protein that is 2,845 amino acids
long (2). In contrast, bioinformatic analyses of the complete E. coli
genome sequences available in the NCBI database showed that
despite being in the same genetic context, there was considerable
variation in the sizes of upaH and the sequence of the repetitive
region (Fig. 1). For example, the largest predicted UpaH open
reading frame (ORF) is 3,161 amino acids long (present in SE15),
while the smallest predicted UpaHORF is 1,940 amino acids long
(present inUMN026) (Fig. 1). These differences could be partially
due to errors in the sequence of the large and highly repetitive
region within the passenger-encoding domain of UpaH, and we
investigated this further by examining additional UPEC strains
for UpaH expression. SDS-PAGE and Western blot analyses with
UpaH antibodies indicated a significant variation in the size of
UpaH in the previously described UPEC strain IA2 (11), as well as
in M369 (a UPEC strain from our laboratory collection), com-
pared to the size of UpaH in theUPEC strains CFT073,M161, and
M357 (Fig. 2A). Notably, the apparent molecular mass of the
UpaHprotein from strain IA2was approximately 200 kDa smaller
than theUpaHprotein from strain CFT073. The identity of UpaH
was confirmed via the construction of isogenic upaH deletionmu-
tants (referred to as M369upaH and IA2upaH); no bands were
observed inWestern blot analyses of these upaH-null strains with
the UpaH antibody (Fig. 2A). To examine if the variation in the
size ofUpaHwas due to glycosylation, we tested for the glycosylation
of UpaH in all five UPEC strains using a commercially available gly-
coprotein-staining kit. In this assay, we saw no evidence of the glyco-
sylation of UpaH (data not shown). Thus, while the UpaH protein is
expressed by multiple UPEC strains, there are significant differences
in the sizes of the protein from different strains.
Cloning and sequencing of upaH gene variants. To examine
the functional consequences of UpaH size variation, the upaH
gene was PCR amplified from the UPEC strains M161, M357,
M369, and IA2 and cloned as a transcriptional fusion down-
stream of the tightly regulated araBAD promoter in the pBAD/
myc-HisA expression vector to generate the plasmids pUpaHM161,
pUpaHM357, pUpaHM369, and pUpaHIA2, respectively. Due to the
very large (2-kb) and highly repetitive region that exists in the
passenger-encoding domain of the upaH gene, an in vitro trans-
poson mutagenesis approach was employed to generate a library
of overlapping transposon mutants, which enabled sequencing
across this region of each gene. The overall lengths of the upaH
genes were different and ranged from 7,581 to 8,538 bp. Transla-
tion of these sequences resulted in predicted UpaH proteins rang-
ing in size from 2,527 to 2,846 amino acids (aa); predicted molec-
ular masses ranged from 258 to 288 kDa (Table 2).
In silico sequence analysis of UpaH variants reveals high se-
quence divergence. A bioinformatic approach was employed to
Allsopp et al.
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compare the amino acid sequences of the five UpaH variants.
Analyses using InterProScan (82) and the Simple Modular Archi-
tecture Design Tool (SMART) (40) identified the presence of a
characteristic signal peptide, parallel -helix repeats (PbH1) and
the SCOP d1dbga from the pectin lysase-like superfamily (known
to have a predominant secondary structure of right-handed par-
allel-helix topology) within the passenger domain of eachUpaH
variant. The presence of an AT -domain was also confirmed in
the C-terminal translocation domain of each variant (Fig. 2B).
The amino acid sequences of the five UpaH variants were
aligned using ClustalW and displayed an amino acid sequence
identity of 53% across the full length of the protein. The highest
percentage sequence identitywas observed between the 300 amino
acids in the N- and C-terminal regions of each protein (93% and
92% identity, respectively) (see Fig. S1 in the supplemental mate-
rial). Conversely, more extensive amino acid sequence variation
was observed in the remainder of the protein (43%). Different
numbers of the 24- to 25-aa short degenerative repeat motif pre-
viously described in UpaHCFT073 were identified in the remainder
of the protein, ranging from39 repeats inUpaHIA2 to 52 repeats in
UpaHM161 (Table 2). A similar repeat configurationwas also iden-
tified after an independent analysis of eachUpaHvariant using the
Rapid Automated Detection and Alignment of Repeats (RADAR)
(26) program (Table 2). The region immediately following these
short repeats exhibited the greatest sequence variation and con-
tained a series of longer, more disordered, repeats as predicted by
RADAR (Fig. 2B; see also Fig. S1).
FIG 1 Evolutionary relationships and genome context of UpaH. The evolutionary history of UpaH (red) was inferred using the neighbor-joining method, and
its genome context was compared in 19 E. coli strains. The bootstrap consensus tree was drawn to scale, and the evolutionary distances were computed using the
p-distance method in MEGA5 (70). The genome context and gene variability were evaluated using complete and annotated E. coli genome sequences in Easyfig
(67). Core (black) and variable (gray) genes are compared to those in the upaH-negative E. coli strain IAI1.
FIG 2 (A) Western blot analysis of UpaH production in whole-cell lysates pre-
pared from E. coli strains CFT073,M161,M357,M369, and IA2 and their respec-
tiveupaHorhnsmutants. (B)Schematic illustrationof thedomainorganizationof
UpaH from E. coli. Indicated are the signal peptide, the small repeat region, the
longer repeat region, and the transmembrane-domain. The repeat regions con-
tain the majority of the sequence differences identified in the UpaH variants.
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UpaHvariantsmediate different levels of biofilm formation.
In order to assess the possible differences in function between the
UpaH variants, the upaH gene was PCR amplified from strains
CFT073, M161, M357, M369, and IA2, cloned into the pBAD-
myc-HisA vector, and expressed in the E. coli K-12 flu gfp-tagged
strain OS56 (65). This strain is unable to mediate the classical cell
aggregation and biofilm phenotypes associated with Ag43 expres-
sion (46). Western blot analyses using UpaH-specific antiserum
detected the UpaH protein in whole-cell lysates prepared from
the E. coli strain OS56 containing pUpaHCFT073, pUpaHM161,
pUpaHM357, pUpaHM369, and pUpaHIA2 following growth in LB
containing 0.2% arabinose. In all cases, the size of the UpaH pro-
tein expressed from each plasmid construct matched that ob-
served in the analysis of the corresponding wild-type strain (data
not shown). Consistent with a previous report for UpaHCFT073
(2), the size of the UpaH protein variants was significantly larger
than the corresponding predicted molecular mass and ranged
from 290 to 460 kDa. A similar level of UpaH expression was
detected from each of the plasmid constructs in the E. coli strain
OS56 (data not shown).
The ability tomediate biofilm formation after expression in the
E. coli OS56 strain was assessed for each of the UpaH variants
under dynamic conditions using the continuous-flow chamber
model. This system permits monitoring of the bacterial distribu-
tion within an evolving biofilm at the single-cell level due to the
combination of scanning confocal laser microscopy and GFP-
taggedOS56 cells. In this assay, all of the UpaH variants promoted
significantly increased biofilm growth at 24 h compared to that of
the E. coli OS56(pBAD/myc-HisA) negative control after induc-
tion with arabinose (Fig. 3A and B). Comparative analysis of the
biofilm formed by each of the UpaH variants revealed significant
differences in level of biovolume (P 0.001), substratum cover-
age (P  0.002), surface area-to-biovolume ratio (P  0.001),
vertical spreading (P  0.001), mean thickness (P  0.006), and
biofilm roughness (P  0.002) (Fig. 3A and B). Similar results
were also obtained following 16 h of biofilm growth (data not
shown). Taken together, these results demonstrate that the UpaH
variants mediate different levels of biofilm formation when ex-
pressed from the same vector system (in the same host back-
ground), and we attribute this to differences in their passenger-
domain sequence.
UpaH mediates adherence to extracellular matrix proteins.
We employed an ELISA-based method to study the adhesive
properties of the UpaH variants to ECM proteins following ex-
pression in the E. coliOS56 strain. Initially, we tested the ability of
the UpaH variants to mediate adherence to MaxGel human ECM
(Sigma-Aldrich), a commercially available mixture of ECM com-
ponents, including collagens, laminin, fibronectin, tenascin, elas-
tin, proteoglycans, and glycosaminoglycans. All of the UpaH vari-
ants promoted significant binding to MaxGel (Fig. 3C). To more
specifically examine this adherence, we then tested the binding of
the UpaH variants to a specific set of ECM proteins. The UpaH
variants all promoted binding to collagen V, fibronectin, and
laminin but not to collagen IV, fibrinogen, or BSA (Fig. 3C and
data not shown). Thus, UpaH promotes specific binding to some
ECM proteins, and this adherence property is conserved among
different variants.
Identification and mutation of hydrophobic and conserved
regions of UpaH. Binding to ECMmolecules has also been dem-
onstrated for several other AT proteins, including YadA, a trim-
eric AT adhesin from Yersinia enterocolitica (4, 25, 27, 68, 69, 71).
YadA possesses the ability to mediate adherence to ECM proteins
such as fibronectin, laminin, and collagen. YadA has a hydropho-
bic domain of 22 amino acids (corresponding to amino acids 55 to
76 of the mature protein) that when deleted results in the loss of
collagen binding (66, 69). We investigated the N-terminal 300-
amino-acid region of UpaH and identified a hydrophobic seg-
ment of 25 amino acids (corresponding to residues 44 to 68 of
the mature UpaHCFT073 protein) that is highly conserved in all of
the variants examined in this study (Fig. 4A; see also Fig. S1 in the
supplemental material). We hypothesized that this region may
confer the binding of UpaH to collagen V and other ECM pro-
teins and investigated this further by modifying the upaH gene
in pUpaHCFT073 through deletion of the hydrophobic region
(pUpaHHR, lacking amino acids 44 to 68 of the mature protein)
or the majority of the conserved region (pUpaHCR, lacking amino
acids 6 to 192 of the mature protein) (Fig. 4A). The CFT073
UpaHHR and UpaHCR proteins were produced in equivalent
amounts as determined by Western blot analyses of whole-cell
lysates (data not shown) and effectively translocated to the cell
surface of E. coli strain OS56, as demonstrated by immunoflu-
orescence microscopy performed with UpaH-specific antisera
on E. coli strains OS56(pUpaHHR), OS56(pUpaHCR), and
OS56(pUpaH; control) following induction with arabinose dur-
ing growth in LB (Fig. 4B). No reaction was seen with E. coli strain
OS56(pBAD) cells (Fig. 4B).
Mutation of the hydrophobic and conserved regions of
UpaH affects biofilm formation. To examine the phenotype of
E. coli cells expressing UpaHHR or UpaHCR, we tested the ability
of E. coli strains OS56(pUpaH), OS56(pUpaHHR), and
OS56(pUpaHCR) to bind to ECM proteins and form a biofilm. In
the ECMassay, the three strains bound at similar levels toMaxGel,
collagen V, fibronectin, and laminin, demonstrating that the abil-
ity to bind to ECM proteins is not dependent on these regions of
UpaH (Fig. 4C).However, in the flow cell assay, comparative anal-
yses of the biofilm formed by each strain revealed significant dif-
TABLE 2 Analysis of UpaH variants found in different UPEC strains
Origin of upaH
(UPEC strain) Size (bp) Size (aa)
Predicted molecular
mass (kDa)
No. of acidic
amino acids
% acidic
amino acids
No. of repeats
predicted by
RADAR
No. of
repeatsa
CFT073 8,538 2,846 288 376 13.2 50 50
M161 8,538 2,846 288 378 13.3 50 52
M357 8,463 2,821 287 375 13.3 47 47
M369 7,818 2,606 265 331 12.7 40 41
IA2 7,581 2,527 258 323 12.8 36 37
a Number of repeats present using the degenerative repeat motif (XGXXXXGXXAXXXXXGXXXXXX) based on the repeats identified in UpaHCFT073.
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ferences in level of biovolume (P  0.001), substratum coverage
(P 0.003), vertical spreading (P 0.001), mean thickness (P
0.002), and biofilm roughness (P  0.001) (Fig. 4D). In the flow
cell, pUpaH formed a thick biofilm, as previously observed (Fig.
3A and B and 4D) (2). The expression of UpaHHR resulted in
reduced vertical spreading but maintained clear substratum cov-
erage in comparison to the overexpression of pUpaH, while
expression of UpaHCR did not promote any biofilm growth
(Fig. 4D). Thus, the ability to mediate biofilm formation is dra-
matically affected by both the hydrophobic and the conserved
regions of UpaH.
A high degree of sequence variation is present in UpaH se-
quences. The conserved N-terminal 300 amino acids identified in
this study were used to investigate the variation in UpaH se-
quences present in the E. coli genomes available in the NCBI da-
tabase. This region was chosen to avoid the repetitive region due
to the inherent difficulties of sequencing long stretches of repeti-
tive DNA, the problems associated with aligning these sequences,
and the high error rate for repetitive sequences in draft genomes.
Interestingly, when the N-terminal 300 amino acids of 143 UpaH
homologues (5 obtained via sequencing in this study and 138 from
theNCBI database) were analyzed usingMEGA5 (70), the entero-
hemorrhagic E. coli (EHEC) and extraintestinal pathogenic E. coli
(ExPEC) (UPEC, asymptomatic bacteriuria [ABU], neonatal
meningitis E. coli [NMEC]) sequences were grouped roughly into
separate clades (Fig. 5). There are significant differences between
these two clades; for example, the N-terminal 300 amino acids of
the strains 1.2741 (EHEC clade) and CFT073 (ExPEC clade) share
38% sequence identity. The difference between these two clades
extends throughout themajority of the passenger domain (see Fig.
1, UMN026 versus 536). As an example, the entire passenger do-
main (1 to 2,527 aa) of UpaH from strains CFT073 and 1.2741
contains 38.3% sequence identity, compared to 84.3% sequence
identity in the predicted -barrel domain. The clades identified in
the alignment of the N-terminal 300 amino acids also accurately
reflect the branches present in the tree generated from 19 UpaH
sequences obtained fromcomplete genomes that contain an intact
open reading frame (Fig. 1 and 5).
Transcription of the upaH variant alleles is regulated by the
H-NS silencing protein.The observation thatUpaHvariants pos-
sess domains with conserved or divergent functional roles
prompted us to examine the regulation of these different upaH
alleles at the transcriptional level. To facilitate this, we inserted a
lacZ reporter as a transcriptional fusion to the promoter of the
upaH gene on the chromosome of CFT073lacI-Z to generate the
strain CFT073lacI-Z upaH::lacZ-zeo. We subsequently created
specific gene deletions in CFT073lacI-Z upaH::lacZ-zeo by -red-
mediated homologous recombination in a series of known/puta-
tive regulatory genes: c0421 (virF-like), c1699 (rpoS), c1701 (hns),
c2091 (virF-like), c2411 (hns-like), c3218 (stpA), c3244 (luxS; AI-
2), c3744 (virF-like), c4864 (cpxR; periplasmic stress), and c5054
(soxR; oxidative stress). Each of these mutants was then assayed
for -galactosidase activity to assess the effect of the deletion of
each regulatory gene on transcription from the upaH pro-
moter. The CFT073lacI-Z upaH::lacZ-zeo hnsmutant exhibited
a 32-fold increase in -galactosidase activity compared to that
of CFT073lacI-Z upaH::lacZ-zeo, while no significant differences
were observed for the other specific gene deletion mutants
(Fig. 6A and data not shown). No color heterogeneities on X-Gal
plates were observed among the CFT073lacI-Z upaH::lacZ-zeo
FIG 3 UpaH variants mediate different levels of biofilm formation in E. coli.
(A) Overhead-view and (B) 3D-reconstructed fluorescence micrographs of bio-
films formedunder continuousflow in thedynamic-flow-chamber assaybyE. coli
OS56 strains expressing different UpaH variants (pUpaHCFT073, pUpaHM161,
pUpaHM357, pUpaHM369, pUpaHIA2, or pBAD). Biofilm development was mon-
itoredvia scanningconfocal lasermicroscopyof theGFP-taggedE. coli strainOS56
cells induced with arabinose. The images in panel A are representative horizontal
sections collected within each biofilm and vertical sections (the right panel and
above each larger panel, representing the yz plane and the xz plane, respectively).
Under 24 h of continuous flow, UpaH variants promoted biofilm growth with
significant differences in level of biovolume (P  0.001), substratum coverage
(P 0.002), vertical spreading (P 0.001), surface area-to-biovolume ratio (P
0.001),mean thickness (P 0.005), andbiofilm roughness (P 0.001).Measure-
ments were analyzed using COMSTAT and the Kruskal-Wallis test. These results
demonstrate that UpaH variants resulted in different levels of biofilm formation
when expressed from the same plasmid and in the same host background. (C)
UpaHvariants thatmediateE. colibinding toMaxGel, collagenV,fibronectin, and
laminin in ELISA-based binding to the same levels. The bar charts represent the
average absorbance measurements at 405 nm of 4 independent experiments plus
the standard errors of themean (SEM).Themean absorbance readingswere com-
pared with negative control readings for OS56(pBAD).
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FIG 4 (A) Schematic illustration of the domain organization of UpaH, UpaHHR, and UpaHCR and a summary of phenotypic results. Indicated are the signal peptide,
the hydrophobic region, the conserved region, the small repeat region, the longer repeat region, and the transmembrane-domain. (B) Immunofluorescence (top) or
phase-contrast (bottom) microscopy employing UpaH-specific antiserum against the cells of the specified E. coli strains. Strains were grown in the presence of 0.2%
arabinose.Theovernight cultureswerefixed and incubatedwith anti-UpaHserumfollowedby incubationwith goat anti-rabbit IgGcoupled toAlexaFluor 350. Positive
reactions indicating surface localization ofUpaH,UpaHHR, andUpaHCRwere detected. (C)UpaH,UpaHHR, andUpaHCRmediate E. coli binding toMaxGel, collagen
V, fibronectin, and laminin in ELISA-based binding to the same levels. The bar charts represent average absorbance measurements at 405 nm of 3 independent
experiments plus the SEM. Themean absorbance readings were comparedwith negative control readings from strainOS56(pBAD). (D)UpaHmutants deleted for the
hydrophobic or conserved region thatmediates different levels of biofilm formation in E. coli. Shown are the overhead views of biofilms formed under continuous flow
by E. coliOS56 strains expressing pUpaHCFT073, pUpaHHR, pUpaHCR, or pBAD. Biofilm development was monitored via scanning confocal laser microscopy of the
GFP-taggedE. coli strainOS56 cells. The images are representative horizontal sections collectedwithin each biofilm and vertical sections (the right panel and above each
larger panel, representing the yz plane and the xz plane, respectively). Under 24 h of continuous flow, the UpaH mutants affected biofilm growth with significant
differences in level of biovolume (P 0.001), substratumcoverage (P 0.003), vertical spreading (P 0.001),mean thickness (P 0.002), andbiofilm roughness (P
0.001). Measurements were analyzed using COMSTAT and the Kruskal-Wallis test. These results demonstrate that expression of pUpaHCFT073, pUpaHHR, and
pUpaHCR resulted in different levels of biofilm formation when expressed from the same plasmid and in the same host background.
Allsopp et al.
5776 jb.asm.org Journal of Bacteriology
 o
n
 O
ctober 13, 2015 by University of Queensland Library
http://jb.asm.org/
D
ow
nloaded from
 
colonies or subsequent mutants, indicating that the expression of
UpaH is apparently not subjected to phase variation. The comple-
mentation of the CFT073lacI-Z upaH::lacZ-zeo hns mutant with
an hns-containing plasmid (pH-NS) resulted in a significant re-
duction in -galactosidase activity (Fig. 6A). Thus, transcription
of the upaH gene is derepressed in a CFT073 hnsmutant.
To investigate whether H-NS influences gene expression by
direct binding to the promoter region of the upaH gene, we per-
formed electrophoretic mobility shift assays. The 250-bp PCR
product was mixed with TaqI-SspI-digested pBR322 DNA, which
contains the bla promoter previously shown to be bound byH-NS
(5, 43, 83), incubated with increasing concentrations of purified
H-NS protein and subsequently visualized by gel electrophoresis.
The 250-bp upaH promoter region and the fragment containing
the bla promoter were retarded in theirmobility by the addition of
0.5MH-NS (Fig. 6B). The pBR322 fragments not containing the
FIG 5 Evolutionary relationships of UpaH. The evolutionary relationship of UpaH was inferred using the N-terminal 300 amino acids of 143 upaH-positive E.
coli strains. The neighbor-joining method was used, and the bootstrap consensus tree was taken to represent the evolutionary history of the taxa analyzed in
MEGA5 (70). The branches corresponding to partitions reproduced in less than 50% of the bootstrap replicates are collapsed. The tree is drawn to scale, and the
distances were computed using the p-distance method. The E. coli strains are color coded according to their pathotypes, and the UPEC strains used in this study
are indicated by an asterisk.
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bla promoter were not influenced by H-NS at these concentra-
tions, indicating that H-NS binds with specificity. These results
suggest that H-NS binds to the regulatory region of the upaH gene
by recognizing a DNA region within 250 bp upstream of the ATG
translation start codon. Comparative analyses of the upaH pro-
moter region from UPEC strains CFT073, M161, M357, M369,
and IA2 revealed several nucleotide differences (data not shown).
An in silico-generated curvature-propensity plot calculated with
DNase I-based parameters for the upaH variants suggested that
the promoter regions of upaHmay adopt a curved conformation,
consistent with its ability to bind toH-NS. The curvature-propen-
sity plot for upaH from strains CFT073, M161, M357, and IA2
revealed an almost identical curved conformation, while the upaH
promoter from M369 contained an additional peak in the curva-
ture-propensity plot caused by a singleG-to-A change at ATG-168
(Fig. 6C and data not shown). To demonstrate this curvature ex-
perimentally, we amplified the 250-bp PCR products containing
the predicted upaH promoter regions and examined them by
polyacrylamide gel electrophoresis at 4°C. This method has been
used previously to demonstrate DNA curvature (73, 81). Consis-
tent with our in silico analysis, we found that both 250-bp upaH
promoter regions displayed retarded gel electrophoretic mobility
compared to noncurved DNA standards, with the mobility of the
upaH promoter region fromM369 impededmore than the corre-
sponding region from CFT073 (Fig. 6D).
The DNA curvature identified in the promoter region of the
upaH variants prompted us to examine the effect of H-NS on
UpaH production from CFT073, as well as UPEC strains M161,
M357, M369, and IA2. Isogenic hns deletion mutants were con-
structed for all five UPEC strains and UpaH production was ex-
amined via Western blot analysis. The loss of H-NS from strains
CFT073, M161, M357, M369, and IA2 resulted in the increased
expression of UpaH (with evidence of protein degradation)
(Fig. 2A). The overexpression of UpaH also resulted in multiple
smaller bands presumed to be breakdown products, consistent
with previous reports (Fig. 2A) (2). Thus, H-NS negatively regu-
lates the expression of upaH in UPEC, and this property is con-
served despite variation in the upaH coding region.
DISCUSSION
Bacterial adhesins mediate attachment to host tissues and provide
the first critical step in colonization. UPEC possesses a range of
different adhesins, many of which belong to the AT class of
proteins. We recently described the identification and charac-
terization of the UpaH AT protein from UPEC CFT073 (2).
Here we show that the sequences of UpaH vary between differ-
FIG 6 H-NS represses upaH expression. (A) -Galactosidase assay of upaH::lacZ-zeo reporter fusions in strain CFT073, isogenic hns deletion mutant, comple-
mented mutant, and complement vector control. (B) Electrophoretic band shift of the amplified 250-bp upaH promoter and the bla promoter from TaqI-SspI-
digested pBR322 DNA in the presence of increasing concentrations of H-NS (0.05, 0.1, 0.2, 0.5, 1, and 2 M). The pBR322 fragments not containing the
bla-promoter (313/315 bp and 475 bp) were not shifted by H-NS. (C) Curvature-propensity plot of the sequence (250 bp) upstream of the upaH gene from
CFT073(PupaHCFT073) and M369(PupaHM369) showing the predicted regions of curved DNA. (D) Curved DNA PAGE gel of the amplified 250-bp promoters
PupaHCFT073 and PupaHM369.
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ent UPEC strains and that this sequence variation is associated
with differences in the abilities of UpaH proteins to mediate
biofilm formation. In contrast, all of the UpaH variants exam-
ined in this study retained a conserved ability to mediate bind-
ing to ECM proteins.
UpaH is the largest AT protein described from UPEC. UpaH
from CFT073 (UpaHCFT073) is a 2,845-amino-acid protein that
comprises a typical AT domain structure: an N-terminal signal
sequence, a passenger domain, and a C-terminal translocation
domain. The passenger domain ofUpaHCFT073 contains 50 imper-
fect repeats, each of which comprises 24 to 25 amino acid residues
(2). In this study, we cloned and sequenced the upaH gene from
four additional UPEC strains. This required the generation of li-
braries of overlapping transposon mutants to sequence across the
highly repetitive passenger-encoding domain of each upaH vari-
ant. The sizes of the upaH genes from theUPEC strains varied; this
was reflected by differences in the numbers of short repeat se-
quences in each variant. Short repeat sequences are common to
the AIDA-I AT group and have been analyzed within the passen-
ger domain of the TibA, AIDA-I, and Ag43 AT proteins from E.
coli (6, 12, 30, 34, 78). AIDA-I contains 21 repeats built up of 19 to
20 amino acid residues followed, after a short interruption, by an
additional 10 repeats. The repeat structure of Ag43 is less well
defined and more variable in length (12 to 20 amino acids). Like
these proteins, the repeating sequence pattern in the passenger
domain of the UpaH variants suggests that this region is predom-
inantly -helical in structure. The variable repeat sequence struc-
ture in each of the upaH variants also indicates that they are prone
to internal expansion or collapsewhilemaintaining gene integrity.
The region immediately following these repeats consisted of lon-
ger, more disordered, repeats that contained less variation in size
but more variation in sequence. The evolution of the upaH gene
may be driven by amplification/deletion of repeats, resulting in
various numbers of repeat sequences, as well as acquisition/loss of
whole blocks of sequences, resulting in new domains.
We observed a significant difference in the abilities of the
UpaH variants to mediate biofilm formation in a dynamic flow
cell system. These differences did not correspond to the number of
short repeat sequences in each variant; UpaHCFT073 (50 short re-
peats) and UpaHM369 (40 short repeats) promoted the strongest
biofilm, while UpaHM161 (50 short repeats), UpaHIA2 (36 short
repeats), and UpaHM357 (47 short repeats) all produced a biofilm
that was more diffuse in structure. This result is in contrast to
recent studies on the Hap and Cha AT proteins from Haemophi-
lus, where large deletions or expansion of the repetitive region
from each protein negatively affects bacterial aggregation (45, 64).
A difference in the ability to mediate biofilm formation has also
been reported for the twoAg43 variants of CFT073. In the flow cell
system, Ag43a mediates strong biofilm formation compared to
Ag43b (72). It is possible that specific residues within the repeat
sequences of UpaH and Ag43 contribute to differences in the abil-
ities of both proteins to mediate biofilm formation. However, di-
rect demonstration of this by site-directedmutagenesis represents
a major challenge for proteins, like UpaH, that contain very large
repeats.
A conserved property of all of the UpaH variants examined in
this study was the ability to bind to ECM proteins. Significant
UpaH-mediated binding was observed to collagen V, fibronectin,
and laminin. Binding to ECM molecules has also been demon-
strated for other AT proteins, including Ag43, AIDA-I, UpaG, and
YadA (27, 39, 54, 69, 71, 74). The YadA trimeric AT adhesin from
Yersinia enterocolitica has been extensively characterized (4, 25,
27, 68, 69, 71). YadA possesses multiple virulence-associated
properties, including the ability to mediate adherence to ECM
proteins, such as fibronectin, laminin, and collagen. YadA has a
hydrophobic domain of 22 amino acids (corresponding to amino
acids 55 to 76 of the mature protein) that when deleted results in
the loss of collagen binding (66, 69). Interestingly, UpaH also
contains a hydrophobic region of 25 amino acids (corresponding
to residues 44 to 68 of the UpaHCFT073 protein) in its N terminus
that is highly conserved in all of the variants examined in this
study. This region is also highly conserved (88 to 100%amino acid
sequence identity) in all 90 of the UpaH sequences from the Ex-
PEC clade compared to in the EHEC clade (39 to 64% amino acid
sequence identity), and we hypothesized that it may confer bind-
ing of UpaH to collagen V and other ECM proteins. However, we
showed that the deletion of this region (UpaHHR), or even a larger
conserved segment spanning this region (UpaHCR), did not re-
duce ECM binding. Although cells overexpressing UpaH exhib-
ited a strong hydrophobicity index compared to cells that did not
express UpaH, the deletion of the HR or CR regions also did not
significantly reduce cell hydrophobicity (data not shown). Thus, it
is possible that the conserved ECM binding mediated by UpaH,
UpaHHR, and UpaHCR may be associated with an overall change
in cell surface hydrophobicity.Wenote thatwe cannot rule out the
possibility that the binding of UpaH to ECM proteins is mediated
by the short repeat sequences in the passenger domain. Indeed, a
similar structural configuration built by multiple short repeat se-
quences has been shown to mediate the binding of the Candida
albicans adhesin Als5p to fibronectin (53).
In contrast to ECM proteins, the UpaHHR and UpaHCR pro-
teins exhibited a reduced capacity to promote biofilm formation.
Thismay be a direct effect resulting fromdeletion of these regions.
Alternatively, the deletion of theHRorCRmay alter the folding of
the short and/or long repeat regions of UpaH, thus altering the
tertiary structure of the protein. We also note that the HR and CR
overlap, such that deletion of the CR also removes theHR. Indeed,
the expression of UpaHCR did not promote biofilm formation in
the flow cell assay.
A role for H-NS in the regulation of the upaH gene was dem-
onstrated in several independent experiments. At the transcrip-
tional level, a significant increase in upaH promoter activity was
observed in a CFT073lacI-Z upaH lacZ-zeo hns mutant. Consis-
tent with this result, we also observed an increase in the produc-
tion of the UpaH protein by CFT073 and five other UPEC strains
in an hnsmutant background. H-NS is a histone-like DNA-bind-
ing protein that shows affinity for A-T-rich and bent nucleation
sites onDNA (17, 18). Previous studies have shown that mutation
of the hns gene in the UPEC strain 536 results in the derepression
ofmultiple virulence factors, including alpha-hemolysin, iron up-
take systems, and fimbriae (48). Our data demonstrate that H-NS
acts as a repressor of upaH transcription, most likely through di-
rect binding to a region comprising the 250 bp upstream of the
upaH open reading frame. The modulation of H-NS expression
may represent a mechanism by which UPEC controls the coordi-
nated expression of virulence genes during colonization of the
urinary tract. Indeed, analysis of the microarray data fromMuller
et al. (48) showed that transcription of the truncated E. coli K-12
upaH gene was approximately 17 times higher in an hns mutant.
Furthermore, in the UPEC strain 536 (which contains an intact
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upaH gene), upaH transcription was approximately five times
higher in an hnsmutant (48). Interestingly, H-NS has been shown
to exert the opposite effect on the transcription of aidA (which
encodes AIDA-I), where it acts as an activator (7). We have also
previously shown that upaH is transcribed by CFT073 voided in
the urine of mice in our UTI model (2). It is possible that the
transcription of upaH is coordinated with other H-NS-repressed
adhesin genes. Indeed, H-NS also represses the expression of the
recently described upaC gene from the UPEC strain CFT073,
which encodes an AT protein associated with adherence to ECM
proteins (1). H-NS is also involved with the regulation of type
1-fimbria expression (16). In addition, several cryptic E. coli K-12
chaperone-usher fimbrial operons that have orthologs in UPEC
genomes were also recently shown to be repressed by H-NS (36).
This suggests that in UPEC, H-NS may coordinate the expression
of multiple virulence factors.
H-NS has a role in nucleoid organization and acts as a global
regulator of gene expression (17). In the Salmonella enterica sero-
var Typhimurium, H-NS represses the transcription of multiple
virulence genes, in particular those located on A-T-rich pathoge-
nicity islands (22, 42, 51). Related enteric bacteria also utilize the
levels of histone-like nucleoid structuring proteins to constrain
virulence gene expression (17, 50). Further investigation is re-
quired to determine if specific conditions encountered by UPEC
in the urinary tract lower intracellular levels of H-NS, or perhaps
alter its binding affinity, to increase the expression of UpaH. Such
conditions would also derepress other H-NS-regulated genes
and thus lead to the coordinated expression of multiple viru-
lence factors.
The bioinformatic analysis of upaH from multiple genome-
sequenced strains revealed that the gene is always found in the
same genetic context. Despite this, the sequences of the upaH
genes were shown to vary between different strains. To explore
this sequence variability of UpaH independently of the repeat re-
gions, we identified a 300-amino-acid nonrepetitive region in the
N-terminal regions of 143 strains and compared these nonrepeti-
tive regions. Using this sequence, we showed that UpaH variants
can be grouped into defined clades. Several of the UpaH variants
that clade separately were analyzed and shown to varywith respect
to their capacity to mediate biofilm formation. Further analysis of
UpaH functions could be targeted to the study of variants from
distinct clades (e.g., UMN026, IAI39). It is also noteworthy that
the 300-amino-acid sequences of the conserved region of UpaH
proteins differed significantly between ExPEC and EHEC patho-
types. This suggests the possibility that UpaH variation may be
associated with pathotype-specific functions and host tissue tro-
pism. This remains to be determined, as does the integrity of the
upaH gene in EHEC,which is disrupted by an insertion element or
a frameshift mutation in many genome-sequenced strains.
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